CDH2 and neoplasm: In solid-tissue cancers outside the CNS, tumour invasion and EMT are driven by an E-cadherin to N-cadherin switch (Thiery et al, 2009), characterised by the loss of E-cadherin and a concomitant increase in N-cadherin.